We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00440726
Recruitment Status : Completed
First Posted : February 27, 2007
Last Update Posted : July 3, 2012
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium